Resultats de la cerca - Robb, M

Isolation of hybridoma cell lines and characterization of monoclonal antibodies against cholera enterotoxin and its subunits. per Robb, M, Nichols, J C, Whoriskey, S K, Murphy, J R

Obtenir text complet
Obtenir text complet
Obtenir text complet

Gastrointestinal Colonization by Candida albicans Mutant Strains in Antibiotic-Treated Mice per Wiesner, Stephen M., Jechorek, Robert P., Garni, Robb M., Bendel, Catherine M., Wells, Carol L.

Obtenir text complet
Obtenir text complet
Obtenir text complet

Referral and access to care of HIV prevalent cases; experience from the early capture HIV cohort study in Kampala per Mutengu LN, Kibuuka H, Millard M, Sekiziyivu A, Wakabi S, Nanyondo J, Kawooya G, Robb M, Michael N

Pattern of HIV risk behavior in a cohort of high risk women in East Africa per Kibuuka HN, Rono K, Maganga L, Millard M, Sekiziyivu A, Maboko L, Shaffer D, Valenzuela A, Michael N, Robb M

Use of patient flow analysis to improve patient visit efficiency by decreasing wait time in a primary care-based disease management programs for anticoagulation and chronic pain: a... per Shilliday Betsy, Malone Robb M, Potisek Nicholas M, Ives Timothy J, Chelminski Paul R, DeWalt Darren A, Pignone Michael P

Obtenir text complet

Global distribution, trends, and drivers of flash drought occurrence per Jordan I. Christian, Jeffrey B. Basara, Eric D. Hunt, Jason A. Otkin, Jason C. Furtado, Vimal Mishra, Xiangming Xiao, Robb M. Randall

Obtenir text complet

Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults per Joachim A, Nilsson C, Aboud S, Lyamuya EF, Robb M, Marovich M, Ochsenbauer C, Wahren B, Sandström E, Biberfeld G, Ferrari G, Polonis VR

Early immune events during acute HIV infection per Slike BM, Tassaneetrithep B, Nitayaphan S, Rono K, Sanga E, Sekiziyivu A, Stablein D, Eller L, Eller MA, Kim J, Michael N, Robb M, Marovich M

Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 a... per Mascola, J R, Louder, M K, VanCott, T C, Sapan, C V, Lambert, J S, Muenz, L R, Bunow, B, Birx, D L, Robb, M L

Obtenir text complet
Obtenir text complet
Obtenir text complet

Incident cases characterization and deep sequencing provide new insight into multiplicity of infection and HIV evolution in very early acute infection per Kijak G, Sanders-Buell E, Rolland M, Li H, Bates A, Bose M, O'Sullivan A, Eller L, O'Connell R, Shaw G, Michael N, Kim J, Robb M, Tovanabutra S

Evidence for Env-V2 sieve effect in breakthrough SIV _MAC251 infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs per Sina S, Tovanabutra S, Sanders-Buell E, Bates A, Bose M, Howell S, Ibitamuno G, Lazzaro M, O'Sullivan A, Lee J, Cervenka T, Kuroiwa J, Baldwin K, Barouch DH, Robb M, O'Connell R, Michael NL, Kim JH, Rolland M

P14-14 LB. A low dose of multigene, multiclade HIV DNA given intradermally induces strong and broad immune responses after boosting with heterologous HIV MVA per Wahren B, Moss B, Earl P, Michael N, Marovich M, Robb M, Brave A, Hejdeman B, Stout R, Mwanyika L, Mbwana J, Janabi M, Lyamuya E, Aris EA, Moshiro C, Buma D, Francis J, Nilsson C, Aboud S, Bakari M, Biberfeld G, Pallangyo K, Mhalu F, Sandstrom E

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime per Bauer A, Podola L, Haule A, Sudi L, Nilsson C, Mann P, Missanga M, Kaluwa B, Maboko L, Lueer C, Mwakatima M, Aboud S, Bakari M, Currier J, Robb M, Joseph S, McCormack S, Lyamuya E, Wahren B, Sandström E, Biberfeld G, Hoelscher M, Kroidl A, Geldmacher C

Determinations of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma: Reassessment of Parameters Affecting Assay Outcome per Lew, J., Reichelderfer, P., Fowler, M., Bremer, J., Carrol, R., Cassol, S., Chernoff, D., Coombs, R., Cronin, M., Dickover, R., Fiscus, S., Herman, S., Jackson, B., Kornegay, J., Kovacs, A., McIntosh, K., Meyer, W., Michael, N., Mofenson, L., Moye, J., Quinn, T., Robb, M., Vahey, M., Weiser, B., Yeghiazarian, T.

Obtenir text complet
Obtenir text complet
Obtenir text complet

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen per Podola L, Bauer A, Haule A, Sudi L, Nilsson C, Godoy-Ramirez K, Mann P, Missanga M, Kaluwa B, Maboko L, Lueer C, Mwakatima M, Aboud S, Bakari M, Currier J, Robb M, McCormack S, Joseph S, Lyamuya E, Hoelscher M, Wahren B, Sandström E, Biberfeld G, Geldmacher C, Kroidl A

Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine per Munseri P, Kroidl A, Nilsson C, Moshiro C, Aboud S, Joachim A, Geldmacher C, Aris E, Buma D, Lyamuya E, Gotch F, Godoy-Ramirez K, Pallangyo K, Maboko L, Marovich M, Robb M, Hoelscher M, Janabi M, Mann P, Joseph S, Mfinanga S, Stoehr W, Mhalu F, Wahren B, Biberfeld G, McCormack S, Sandstrom E, Bakari M